[Editorial] Editing the human genome: balancing safety and regulation

The international race to bring human genome editing into widespread use in clinical medicine is moving fast. On Jan 23, the National Institutes of Health Common Fund launched its Somatic Cell Genome Editing programme, committing approximately US$190 million of funding over the next 6 years to propel development of genome editing into medical practice. A worthy effort, but the USA and Europe still trail behind China. As many as 86 patients in China have already had their genes altered as part of clinical trials to treat a range of diseases, including solid cancers.
Source: LANCET - Category: General Medicine Authors: Tags: Editorial Source Type: research